FOOTHILL RANCH, Calif., U.S.: Medical device company BIOLASE expects that its U.S. sales revenue for the third quarter of 2020 will be in line with that of the corresponding pre-COVID-19 period last year. The company’s sales fell sharply in the first half of this year, but its preliminary earnings announcement will bring a degree of optimism as a host of major dental companies prepare to release their third quarter earnings reports in the coming weeks.
IRVINE, Calif., U.S.: BIOLASE, a global leader in dental lasers, has reported the results of a clinical trial conducted at the McGuire Institute. Designed to meet the stringent American Academy of Periodontology best-evidence consensus standards, this first-of-its-kind study compared the BIOLASE REPAIR Perio protocol with conventional minimally invasive surgical treatment for moderate to severe generalized periodontitis.
The BIOLASE Academy went live at the end of March. Hosted by leading dental laser manufacturer, BIOLASE, this new online educational platform is dedicated to providing accessible and certified continuing education opportunities to dental professionals working with laser treatments. With periodontal disease possibly the most widespread chronic disease in the world, an upcoming webinar on the platform will present a new therapeutic approach to using lasers in order to improve periodontal treatment outcomes.
The selection of a laser modality must be criteria based, both peri-operatively and post-operatively. Clinical outcomes will help guide the clinician as to when to select soft versus hard tissue ablative lasers for a procedure. This webinar will outline all the requisite criteria-based parameters for Oral Surgery and provide video based examples of surgical procedures as a clinical guide.
A retrospective observational clinical study reports on the efficacy and safety of treatment of various skin esthetic procedures, using the Biolase Er;Cr:YSGG 2780 nm laser connected to the Fractional Handpiece. When benign skin pigment is present, combination with an antipigment-chemicals is apply following the laser pass to trans-epidermally reaching the dermis to target deep located melanin. Also, treatment of scar tissue and cases for skin facial rejuvenation obtained successful outcomes, with patients' high index of satisfaction.
A beautiful smile is more than just the teeth. A harmonious result with cosmetic procedures rely not only on great looking aesthetic restorations but also on healthy symmetrical gum tissues which compliments the new teeth. Combining Cerec Cadcam with Biolase iplus all tissue lasers allows the modern dental office to offer so much more to the ever-increasing patient demand for aesthetic solutions. Synergy between these two amazing technologies transforms the patient experience from that of needing multiple and often painful appointments into a seamless single visit procedure giving immediate results with reduced healing time. Learn how the two technologies complements each other during this webinar.